How much is LENZ Therapeutics worth in 2026?

LENZ Therapeutics has a current valuation of N/A based on their Later Stage VC (Series B) round and secondary market data.

How much funding has LENZ Therapeutics raised?

LENZ Therapeutics has raised N/A in total funding across 2 funding rounds.

LENZ Therapeutics

Drug Discovery

LENZ Therapeutics valuation and funding history | Last updated: March 6, 2023 | 2 funding rounds

Current Valuation

N/A

As of March 6, 2023

Total Funding Raised

N/A

Across 2 rounds

Last Round

Later Stage VC (Series B)

$83.5M

Last Funding

Mar 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 6, 2023	Later Stage VC (Series B)	$83.5M	N/A	-
November 22, 2022	Later Stage VC (Series A)	$49.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

LENZ Therapeutics is currently valued at N/A as of March 6, 2023.

Track LENZ Therapeutics Valuation Updates

Get notified when LENZ Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for LENZ Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock LENZ Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is LENZ Therapeutics Worth in 2026?

LENZ Therapeutics is a leading private company in the Drug Discovery sector. Track LENZ Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How LENZ Therapeutics Valuation is Determined

Private company valuations like LENZ Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.